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Background
Hereditary Angioedema (HAE) is a rare, inherited, autoso-
mal dominant disease caused by a deficiency in C1-ester-
ase inhibitor. It affects one in every 50,000 to 100,000
individuals. There were no approved treatments for HAE
in North America until 2009, when C1-esterase inhibitor
(Berinertâ) was released. It is an intravenous medication
that requires patients to present to an emergency room
(ER) for treatment. We present two cases of patients with
HAE who self-administered the medications, decreasing
their number of emergency room visits substantially.
Methods
Cases were obtained from office visits with an allergist
and continued communication with the patients.
Results
The first patient averaged around 17 visits to an ER per
year. She and her husband are both paramedics and they
were able to start intravenous lines for the required infu-
sion at home. After she began self-administering the medi-
cation, she had no further visits to an emergency room.
The second patient suffered from very frequent attacks
and had poor venous access. In 2009, she had 37 ER visits
and in 2010 alone, 48 visits. A Hickman catheter was
placed in her internal jugular vein for easy access. After
she began self-administration 5 months ago, she has had
only 3 presentations to the ER.
Conclusions
Self-administration of C1-esterase inhibitor (Berinertâ)
dramatically improved the lives of these two young
patients, and resulted in a considerable decrease in the
number of days spent in an emergency room.
Author details
1University of Ottawa, Ottawa, ON, Canada.
2Allergy and Asthma Research
Centre, Ottawa, ON, Canada.
Published: 14 November 2011
doi:10.1186/1710-1492-7-S2-A40
Cite this article as: Rizk et al.: Self-administration of intravenous C1
esterase inhibitor (Berinertâ) in patients with Hereditary Angioedema
decreases number of days spent in an emergency room. Allergy, Asthma
& Clinical Immunology 2011 7(Suppl 2):A40.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit 1University of Ottawa, Ottawa, ON, Canada
Full list of author information is available at the end of the article
Rizk et al. Allergy, Asthma & Clinical Immunology 2011, 7(Suppl 2):A40
http://www.aacijournal.com/content/7/S2/A40 ALLERGY, ASTHMA & CLINICAL 
IMMUNOLOGY
© 2011 Rizk et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.